Showing results (91-100 of 401) with videos related to
Sort By:
Pageof 41
The American Journal of Clinical Nutrition|February 1, 1984
Lactose maldigestion in Ascaris-infected preschool childrenE Carrera, M C Nesheim, D W CromptonThe Journal of Nutrition|October 1, 1981
Effect of energy restriction on total heat production, basal metabolic rate, and specific dynamic action of food in ratsE Forsum, P E Hillman, M C NesheimEuropean Journal of Clinical Pharmacology|January 1, 1991
Comparison of postpartum pain treatments using a sequential trial design. I. Paracetamol versus placeboE Skovlund, G Fyllingen, H Landre, et al.The Journal of Biological Chemistry|January 10, 1983
Proteolytic alterations of factor Va bound to plateletsP B Tracy, M E Nesheim, K G MannCurrent Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disordersM B Boffa, M E Nesheim, M L KoschinskyBritish Journal of Haematology|August 1, 1988
A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivoA R Giles, K G Mann, M E NesheimThe British Journal of Nutrition|February 1, 1994
Dietary level of maize oil affects growth and lipid composition of Walker 256 carcinosarcomaJ M Black, M C Nesheim, J E KinsellaEuropean Journal of Clinical Pharmacology|January 1, 1991
Comparison of postpartum pain treatments using a sequential trial design: II. Naproxen versus paracetamolE Skovlund, G Fyllingen, H Landre, et al.The Journal of Biological Chemistry|February 28, 1998
Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitorL Bajzar, M Nesheim, J Morser, et al.Biochemistry|May 11, 1982
Progressive development of a thrombin inhibitor binding siteL S Hibbard, M E Nesheim, K G MannPageof 41